SPARK has a special focus on the often-neglected diseases, including those in the area of Child and Maternal Health. Thanks to funding from the Stanford Maternal and Child Health Research Institute, 18 projects in this area have reached the clinic or commercial sectors.
SPARK is a unique partnership between the University and industry experts. Building upon Stanford’s tradition of technological innovation and entrepreneurship, Chemical and Systems Biology Professor, Daria Mochly-Rosen, founded the SPARK program, and joined by Professor Kevin Grimes later in the first year, to provide a cost-effective model to generate proof of concept using out-of-the-box academic approaches combined with industry standards.
SPARK provides access to specialized knowledge and technical expertise regarding drug and diagnostic development, dedicated core laboratory facilities, and sources of funding to support translational efforts.
FY 2021 Awards
Eric Appel, PhD
Assistant Professor, Materials Sciense & Engineering
Project Title: An Ultra-Fast Insulin to Improve the Treatment of Diabetes
Maria Barna, PhD
Associate Professor, Genetics
Project Title: Identifying Translational Activators for the Treatment of Diamond Blackfan Anemia
Vivek Bhalla, PhD, Associate Professor, Medicine (Nephrology), and Avnesh Thakor, MD, PhD, Assistant Professor, Radiology (Pediatric Radiology)
Project Title: Gene Therapy for Autosomal Dominant Polycystic Kidney Disease
Ami Bhatt, MD, PhD
Assistant Professor, Medicine (Hematology)
Project Title: Developing Novel Microbial Integrases as Next-Generation Gene Therapies
Kelly Mahaney, MD, MS, Assistant Professor, Neurosurgery, and Jayakumar Rajadas, PhD, Assistant Professor, Medicine (Pulmonary & Critical Care Medicine)
Project Title: Development of Iron Chelation Intraventricular Drug Delivery for Prevention of Post-Hemorrhagic Hydrocephalus (PHH) in Severe Neonatal Intraventricular Hemorrhage (IVH)